Decentralized Manufacturing: Enabling Scalable And Cost-Effective Point Of Care For Cell And Gene Therapies

The transformative potential to change the way human disease is treated using cell and gene therapy has motivated rapid technological advancements towards streamlining manufacturing processes. Standardization via automation and introduction of quality control via closed system manufacturing will contribute to overcoming barriers and facilitate the reach of this treatment to broader patient populations.

Tune into this webinar, Decentralized Manufacturing: Enabling Scalable and Cost-Effective Point of Care for Cell and Gene Therapies, to hear industry leaders from the University College London and Thermo Fisher Scientific as they discuss the evolution of the industry and where it's headed.

Watch now and you'll learn:

• Drivers and challenges associated with decentralized manufacturing
• How streamlined processes can enable scalable point of care
• Closed, modular, automated cell therapy workflow solutions